Stephane Potvin - Publications

Affiliations: 
Université de Montréal, Montréal, Canada 
Area:
Clinical Psychology, Mental Health

89 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Dumont M, Briand C, Leblanc Y, Aubin G, Potvin S, Dumais A. The Integrated Psychological Treatment for Individuals With Schizophrenia in Correctional and Forensic Psychiatric Settings: An Implementation Study. International Journal of Offender Therapy and Comparative Criminology. 306624X19899607. PMID 31941403 DOI: 10.1177/0306624X19899607  0.4
2019 Abdel-Baki A, Thibault D, Medrano S, Stip E, Ladouceur M, Tahir R, Potvin S. Long-acting antipsychotic medication as first-line treatment of first-episode psychosis with comorbid substance use disorder. Early Intervention in Psychiatry. PMID 31125513 DOI: 10.1111/eip.12826  0.56
2019 Tikàsz A, Dumais A, Lipp O, Stip E, Lalonde P, Laurelli M, Lungu O, Potvin S. Reward-related decision-making in schizophrenia: A multimodal neuroimaging study. Psychiatry Research. Neuroimaging. 286: 45-52. PMID 30897449 DOI: 10.1016/j.pscychresns.2019.03.007  0.56
2018 Medrano S, Abdel-Baki A, Stip E, Potvin S. Three-Year Naturalistic Study On Early Use Of Long-Acting Injectable Antipsychotics In First Episode Psychosis. Psychopharmacology Bulletin. 48: 25-61. PMID 30618474  0.56
2018 Tourjman SV, Potvin S, Corbalan F, Djouini A, Purdon SE, Stip E, Juster RP, Kouassi E. Rapid screening for cognitive deficits in attention deficit and hyperactivity disorders with the screen for cognitive impairment in psychiatry. Attention Deficit and Hyperactivity Disorders. PMID 30225804 DOI: 10.1007/s12402-018-0268-7  0.56
2018 Potvin S, Tikàsz A, Richard-Devantoy S, Lungu O, Dumais A. History of Suicide Attempt Is Associated with Reduced Medial Prefrontal Cortex Activity during Emotional Decision-Making among Men with Schizophrenia: An Exploratory fMRI Study. Schizophrenia Research and Treatment. 2018: 9898654. PMID 29686902 DOI: 10.1155/2018/9898654  0.32
2018 Tourjman SV, Juster RP, Purdon S, Stip E, Kouassi E, Potvin S. The screen for cognitive impairment in psychiatry (SCIP) is associated with disease severity and cognitive complaints in major depression. International Journal of Psychiatry in Clinical Practice. 1-8. PMID 29553848 DOI: 10.1080/13651501.2018.1450512  0.56
2018 du Sert OP, Potvin S, Lipp O, Dellazizzo L, Laurelli M, Breton R, Lalonde P, Phraxayavong K, O'Connor K, Pelletier JF, Boukhalfi T, Renaud P, Dumais A. Virtual reality therapy for refractory auditory verbal hallucinations in schizophrenia: A pilot clinical trial. Schizophrenia Research. PMID 29486956 DOI: 10.1016/j.schres.2018.02.031  0.44
2017 Tikàsz A, Potvin S, Richard-Devantoy S, Lipp O, Hodgins S, Lalonde P, Lungu O, Dumais A. Reduced dorsolateral prefrontal cortex activation during affective Go/NoGo in violent schizophrenia patients: An fMRI study. Schizophrenia Research. PMID 29129509 DOI: 10.1016/j.schres.2017.11.011  0.44
2017 Potvin S, Tikàsz A, Lungu O, Stip E, Zaharieva V, Lalonde P, Lipp O, Mendrek A. Impaired Coupling between the Dorsomedial Prefrontal Cortex and the Amygdala in Schizophrenia Smokers Viewing Anti-smoking Images. Frontiers in Psychiatry. 8: 109. PMID 28674507 DOI: 10.3389/fpsyt.2017.00109  0.56
2016 Tikàsz A, Tourjman V, Chalaye P, Marchand S, Potvin S. Increased spinal pain sensitization in major depressive disorder: A pilot study. Psychiatry Research. PMID 27817904 DOI: 10.1016/j.psychres.2016.10.052  0.36
2016 Potvin S, Lungu O, Tikàsz A, Mendrek A. Abnormal effective fronto-limbic connectivity during emotion processing in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 27528110 DOI: 10.1016/j.pnpbp.2016.08.004  0.48
2016 Potvin S, Tikàsz A, Mendrek A. Emotionally Neutral Stimuli Are Not Neutral in Schizophrenia: A Mini Review of Functional Neuroimaging Studies. Frontiers in Psychiatry. 7: 115. PMID 27445871 DOI: 10.3389/fpsyt.2016.00115  0.32
2016 Tikàsz A, Potvin S, Lungu O, Joyal CC, Hodgins S, Mendrek A, Dumais A. Anterior cingulate hyperactivations during negative emotion processing among men with schizophrenia and a history of violent behavior. Neuropsychiatric Disease and Treatment. 12: 1397-410. PMID 27366072 DOI: 10.2147/NDT.S107545  0.48
2016 Lesage A, Lemasson M, Medina K, Tsopmo J, Sebti N, Potvin S, Patry S. The Prevalence of Electroconvulsive Therapy Use Since 1973: A Meta-analysis. The Journal of Ect. PMID 27227401 DOI: 10.1097/YCT.0000000000000320  0.48
2016 Potvin S, Stip E, Marchand S. Markedly Reduced Thermal Pain Perception in a Schizoaffective Patient with Tardive Dyskinesia. Case Reports in Psychiatry. 2016: 8702483. PMID 27144045 DOI: 10.1155/2016/8702483  0.56
2016 Potvin S, Lungu O, Lipp O, Lalonde P, Zaharieva V, Stip E, Melun JP, Mendrek A. Increased ventro-medial prefrontal activations in schizophrenia smokers during cigarette cravings. Schizophrenia Research. 173: 30-6. PMID 27005897 DOI: 10.1016/j.schres.2016.03.011  0.48
2015 Potvin S, Tikàsz A, Dinh-Williams LL, Bourque J, Mendrek A. Cigarette Cravings, Impulsivity, and the Brain. Frontiers in Psychiatry. 6: 125. PMID 26441686 DOI: 10.3389/fpsyt.2015.00125  0.48
2015 Zhornitsky S, Tikàsz A, Rizkallah É, Chiasson JP, Potvin S. Psychopathology in Substance Use Disorder Patients with and without Substance-Induced Psychosis. Journal of Addiction. 2015: 843762. PMID 26417473 DOI: 10.1155/2015/843762  1
2015 Potvin S, Tikàsz A. Response to: A Commentary on "Antipsychotic-Induced Parkinsonism is Associated with Working Memory Deficits in Schizophrenia-Spectrum Disorders". Frontiers in Behavioral Neuroscience. 9: 210. PMID 26321931 DOI: 10.3389/fnbeh.2015.00210  0.32
2015 Lungu O, Potvin S, Tikàsz A, Mendrek A. Sex differences in effective fronto-limbic connectivity during negative emotion processing. Psychoneuroendocrinology. 62: 180-8. PMID 26318628 DOI: 10.1016/j.psyneuen.2015.08.012  0.48
2015 Potvin S, Tikàsz A, Lungu O, Dumais A, Stip E, Mendrek A. Emotion processing in treatment-resistant schizophrenia patients treated with clozapine: An fMRI study. Schizophrenia Research. 168: 377-80. PMID 26255082 DOI: 10.1016/j.schres.2015.07.046  0.48
2015 Mancini-Marïe A, Yoon U, Jiminez J, Fahim C, Potvin S, Grant JA, Laverdure-Dupont D, Dubé AA, Betrisey C, Rainville P, Evans AC, Stip E, Mendrek A. Sex, age, symptoms and illness duration and their relation with gyrification index in schizophrenia. Clinical Schizophrenia & Related Psychoses. PMID 26218234 DOI: 10.3371/CSRP.MAYO.070415  0.56
2015 Potvin S, Zhornitsky S, Stip E. Antipsychotic-induced changes in blood levels of leptin in schizophrenia: a meta-analysis. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 60: S26-34. PMID 25886677  1
2015 Stip E, Potvin S. The 10th Anniversary of the Eli Lilly Chair of Schizophrenia from the University of Montreal. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 60: S1-4. PMID 25886674  0.56
2015 Potvin S, Lungu OV, Stip E. Anandamide is involved in appetite-related amygdala hyperactivations in schizophrenia patients treated with olanzapine: a functional magnetic resonance imaging study. Journal of Clinical Psychopharmacology. 35: 82-3. PMID 25370126 DOI: 10.1097/JCP.0000000000000236  0.56
2015 Potvin S, Aubin G, Stip E. Antipsychotic-induced parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders. European Archives of Psychiatry and Clinical Neuroscience. 265: 147-54. PMID 24925606 DOI: 10.1007/s00406-014-0511-y  0.56
2014 Potvin S, Pelletier J, Stip E. [Neurocognitive insight in schizophrenia: a meta-analysis]. Santé Mentale Au QuéBec. 39: 183-200. PMID 25590551  0.56
2014 Dinh-Williams L, Mendrek A, Dumais A, Bourque J, Potvin S. Executive-affective connectivity in smokers viewing anti-smoking images: an fMRI study. Psychiatry Research. 224: 262-8. PMID 25453167 DOI: 10.1016/j.pscychresns.2014.10.018  0.48
2014 Potvin S, Stavro K, Rizkallah E, Pelletier J. Cocaine and cognition: a systematic quantitative review. Journal of Addiction Medicine. 8: 368-76. PMID 25187977 DOI: 10.1097/ADM.0000000000000066  0.48
2014 Horn M, Potvin S, Allaire JF, Côté G, Gobbi G, Benkirane K, Vachon J, Dumais A. Male inmate profiles and their biological correlates. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 59: 441-9. PMID 25161069  0.48
2014 Paquin K, Wilson AL, Cellard C, Lecomte T, Potvin S. A systematic review on improving cognition in schizophrenia: which is the more commonly used type of training, practice or strategy learning? Bmc Psychiatry. 14: 139. PMID 24885300 DOI: 10.1186/1471-244X-14-139  0.48
2014 Samaha AN, Potvin S. Drugs of abuse and psychiatric disorders: neurobiological and clinical aspects. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 52: 1-3. PMID 24699021 DOI: 10.1016/j.pnpbp.2014.03.012  0.48
2014 Dinh-Williams L, Mendrek A, Bourque J, Potvin S. Where there's smoke, there's fire: the brain reactivity of chronic smokers when exposed to the negative value of smoking. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 50: 66-73. PMID 24361634 DOI: 10.1016/j.pnpbp.2013.12.009  0.48
2013 Tourjman V, Kouassi É, Koué MÈ, Rocchetti M, Fortin-Fournier S, Fusar-Poli P, Potvin S. Antipsychotics' effects on blood levels of cytokines in schizophrenia: a meta-analysis. Schizophrenia Research. 151: 43-7. PMID 24200418 DOI: 10.1016/j.schres.2013.10.011  0.48
2013 Potvin S, Bourque J, Durand M, Lipp O, Lalonde P, Stip E, Grignon S, Mendrek A. The neural correlates of mental rotation abilities in cannabis-abusing patients with schizophrenia: an FMRI study. Schizophrenia Research and Treatment. 2013: 543842. PMID 23970971 DOI: 10.1155/2013/543842  0.56
2013 Bourque J, Mendrek A, Durand M, Lakis N, Lipp O, Stip E, Lalonde P, Grignon S, Potvin S. Cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging study. Psychiatry Research. 214: 24-32. PMID 23906663 DOI: 10.1016/j.pscychresns.2013.05.012  0.48
2013 Bourque J, Mendrek A, Dinh-Williams L, Potvin S. Neural circuitry of impulsivity in a cigarette craving paradigm. Frontiers in Psychiatry. 4: 67. PMID 23874307 DOI: 10.3389/fpsyt.2013.00067  0.48
2013 Zhornitsky S, Wee Yong V, Koch MW, Mackie A, Potvin S, Patten SB, Metz LM. Quetiapine fumarate for the treatment of multiple sclerosis: focus on myelin repair. Cns Neuroscience & Therapeutics. 19: 737-44. PMID 23870612 DOI: 10.1111/cns.12154  0.48
2013 Zhornitsky S, Aubin G, Desfossés J, Rizkallah E, Pampoulova T, Lipp O, Chiasson JP, Stip E, Potvin S. Predictors of community functioning in schizophrenia and substance use disorder patients. Community Mental Health Journal. 49: 317-22. PMID 22847727 DOI: 10.1007/s10597-012-9525-y  1
2013 Stavro K, Pelletier J, Potvin S. Widespread and sustained cognitive deficits in alcoholism: a meta-analysis. Addiction Biology. 18: 203-13. PMID 22264351 DOI: 10.1111/j.1369-1600.2011.00418.x  0.36
2012 Zhornitsky S, Potvin S. Cannabidiol in humans-the quest for therapeutic targets. Pharmaceuticals (Basel, Switzerland). 5: 529-52. PMID 24281562 DOI: 10.3390/ph5050529  1
2012 Lévesque M, Potvin S, Marchand S, Stip E, Grignon S, Pierre L, Lipp O, Goffaux P. Pain perception in schizophrenia: evidence of a specific pain response profile. Pain Medicine (Malden, Mass.). 13: 1571-9. PMID 23170852 DOI: 10.1111/j.1526-4637.2012.01505.x  0.56
2012 Paul-Savoie E, Marchand S, Morin M, Bourgault P, Brissette N, Rattanavong V, Cloutier C, Bissonnette A, Potvin S. Is the deficit in pain inhibition in fibromyalgia influenced by sleep impairments? The Open Rheumatology Journal. 6: 296-302. PMID 23091577 DOI: 10.2174/1874312901206010296  0.48
2012 Desfossés J, Stip E, Bentaleb LA, Lipp O, Chiasson JP, Furtos A, Venne K, Kouassi E, Potvin S. Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the "Mirror Effect" of Schizophrenia. Frontiers in Psychiatry. 3: 85. PMID 23055987 DOI: 10.3389/fpsyt.2012.00085  0.48
2012 Zhornitsky S, Rizkallah E, Pampoulova T, Chiasson JP, Lipp O, Stip E, Potvin S. Sensation-seeking, social anhedonia, and impulsivity in substance use disorder patients with and without schizophrenia and in non-abusing schizophrenia patients. Psychiatry Research. 200: 237-41. PMID 22980481 DOI: 10.1016/j.psychres.2012.07.046  1
2012 Potvin S, Morin M, Cloutier C, Gendron A, Bissonnette A, Marchand S. Add-on treatment of quetiapine for fibromyalgia: a pilot, randomized, double-blind, placebo-controlled 12-week trial. Journal of Clinical Psychopharmacology. 32: 684-7. PMID 22926604 DOI: 10.1097/JCP.0b013e318267b8ca  0.48
2012 Chiasson JP, Stavro K, Rizkallah É, Lapierre L, Dussault M, Legault L, Potvin S. Questioning the specificity of ASRS-v1.1 to accurately detect ADHD in substance abusing populations. Journal of Attention Disorders. 16: 661-3. PMID 22049481 DOI: 10.1177/1087054711425768  0.48
2011 Stip E, Zhornitsky S, Moteshafi H, Létourneau G, Stikarovska I, Potvin S, Tourjman V. Ziprasidone for psychotic disorders: a meta-analysis and systematic review of the relationship between pharmacokinetics, pharmacodynamics, and clinical profile. Clinical Therapeutics. 33: 1853-67. PMID 22133697 DOI: 10.1016/j.clinthera.2011.10.027  1
2011 Rizkallah E, Bélanger M, Stavro K, Dussault M, Pampoulova T, Chiasson JP, Potvin S. Could the use of energy drinks induce manic or depressive relapse among abstinent substance use disorder patients with comorbid bipolar spectrum disorder? Bipolar Disorders. 13: 578-80. PMID 22017226 DOI: 10.1111/j.1399-5618.2011.00951.x  0.48
2011 Rizkallah E, Legault L, Pampoulova T, Lévesque S, Bélanger M, Stavro K, Chiasson JP, Potvin S. A case report of Concerta misuse in a patient with comorbid substance use disorder and attention deficit hyperactivity disorder. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 20: 478-9. PMID 21838849 DOI: 10.1111/j.1521-0391.2011.00158.x  0.48
2011 Zhornitsky S, Stip E, Desfossés J, Pampoulova T, Rizkallah E, Rompré PP, Bentaleb LA, Lipp O, Chiasson JP, Gendron A, Potvin S. Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine. Frontiers in Psychiatry. 2: 22. PMID 21629845 DOI: 10.3389/fpsyt.2011.00022  0.48
2011 Igue R, Potvin S, Bah R, Stip E, Bouchard RH, Lipp O, Gendron A, Kouassi E. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 1695-8. PMID 21627977 DOI: 10.1016/j.pnpbp.2011.05.011  0.48
2011 Dumais A, Potvin S, Joyal C, Allaire JF, Stip E, Lesage A, Gobbi G, Côté G. Schizophrenia and serious violence: a clinical-profile analysis incorporating impulsivity and substance-use disorders. Schizophrenia Research. 130: 234-7. PMID 21441016 DOI: 10.1016/j.schres.2011.02.024  0.48
2011 Paul-Savoie E, Potvin S, Daigle K, Normand E, Corbin JF, Gagnon R, Marchand S. A deficit in peripheral serotonin levels in major depressive disorder but not in chronic widespread pain. The Clinical Journal of Pain. 27: 529-34. PMID 21415718 DOI: 10.1097/AJP.0b013e31820dfede  0.48
2011 Zhornitsky S, Potvin S, Moteshafi H, Dubreucq S, Rompré PP, Stip E. Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials. International Clinical Psychopharmacology. 26: 183-92. PMID 21372722 DOI: 10.1097/YIC.0b013e3283430a0e  0.48
2011 Zhornitsky S, Potvin S, Aubin G, Stip E. Relationship between insight into cognition, extrapyramidal symptoms and mental illness in schizophrenia. The Australian and New Zealand Journal of Psychiatry. 45: 604-5. PMID 21355813 DOI: 10.3109/00048674.2011.561483  1
2011 Chiasson JP, Rizkallah É, Stavro K, Dussault M, Pampoulova T, Tourjman V, Potvin S. Is the Mood Disorder Questionnaire an appropriate screening tool in detecting bipolar spectrum disorder among substance use populations? The American Journal of Drug and Alcohol Abuse. 37: 79-81. PMID 21142433 DOI: 10.3109/00952990.2010.538944  0.48
2011 Normand E, Potvin S, Gaumond I, Cloutier G, Corbin JF, Marchand S. Pain inhibition is deficient in chronic widespread pain but normal in major depressive disorder. The Journal of Clinical Psychiatry. 72: 219-24. PMID 20816025 DOI: 10.4088/JCP.08m04969blu  0.48
2010 Rizkallah E, Stip E, Zhornitsky S, Pampoulova T, Gendron A, Rompré PP, Chiasson JP, Potvin S. Clinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trial. Expert Opinion On Pharmacotherapy. 11: 2947-51. PMID 20979569 DOI: 10.1517/14656566.2010.524927  0.48
2010 Zhornitsky S, Stip E, Pampoulova T, Rizkallah E, Lipp O, Bentaleb LA, Chiasson JP, Potvin S. Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophrenia. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2188-94. PMID 20669315 DOI: 10.1002/mds.23227  1
2010 Zhornitsky S, Rizkallah E, Pampoulova T, Chiasson JP, Stip E, Rompré PP, Potvin S. Antipsychotic agents for the treatment of substance use disorders in patients with and without comorbid psychosis. Journal of Clinical Psychopharmacology. 30: 417-24. PMID 20631559 DOI: 10.1097/JCP.0b013e3181e7810a  0.48
2010 Zhornitsky S, Potvin S, Stip E, Rompré PP. Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 695-703. PMID 20605419 DOI: 10.1016/j.euroneuro.2010.04.011  0.48
2010 Stip E, Zhornitsky S, Potvin S, Tourjman V. Switching from conventional antipsychotics to ziprasidone: a randomized, open-label comparison of regimen strategies. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 34: 997-1000. PMID 20470848 DOI: 10.1016/j.pnpbp.2010.05.010  1
2010 Gallo A, Lapointe S, Stip E, Potvin S, Rompré PP. Quetiapine blocks cocaine-induced enhancement of brain stimulation reward. Behavioural Brain Research. 208: 163-8. PMID 19941909 DOI: 10.1016/j.bbr.2009.11.029  0.48
2009 Potvin S, Blanchet P, Stip E. Substance abuse is associated with increased extrapyramidal symptoms in schizophrenia: a meta-analysis. Schizophrenia Research. 113: 181-8. PMID 19608386 DOI: 10.1016/j.schres.2009.06.010  0.56
2008 Potvin S, Pampoulova T, Lipp O, Ait Bentaleb L, Lalonde P, Stip E. Working memory and depressive symptoms in patients with schizophrenia and substance use disorders. Cognitive Neuropsychiatry. 13: 357-66. PMID 18622790 DOI: 10.1080/13546800802264330  0.56
2008 Stip E, Mancini-Marïe A, Fahim C, Bentaleb LA, Létourneau G, Potvin S. Decrease in basal ganglia grey matter density associated with atypical antipsychotic treatment in schizophrenia patients. Schizophrenia Research. 103: 319-21. PMID 18556174 DOI: 10.1016/j.schres.2008.04.030  0.56
2008 Potvin S, Kouassi E, Lipp O, Bouchard RH, Roy MA, Demers MF, Gendron A, Astarita G, Piomelli D, Stip E. Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy. Journal of Psychopharmacology (Oxford, England). 22: 262-9. PMID 18308802 DOI: 10.1177/0269881107083816  0.48
2008 Redmond WJ, Goffaux P, Potvin S, Marchand S. Analgesic and antihyperalgesic effects of nabilone on experimental heat pain. Current Medical Research and Opinion. 24: 1017-24. PMID 18302810 DOI: 10.1185/030079908X280635  0.48
2008 Potvin S, Stip E, Lipp O, Roy MA, Demers MF, Bouchard RH, Gendron A. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia. The American Journal of Drug and Alcohol Abuse. 34: 75-82. PMID 18161645 DOI: 10.1080/00952990701764631  0.48
2008 Potvin S, Stip E, Tempier A, Pampoulova T, Bentaleb LA, Lalonde P, Lipp O, Goffaux P, Marchand S. Pain perception in schizophrenia: no changes in diffuse noxious inhibitory controls (DNIC) but a lack of pain sensitization. Journal of Psychiatric Research. 42: 1010-6. PMID 18093615 DOI: 10.1016/j.jpsychires.2007.11.001  0.56
2008 Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biological Psychiatry. 63: 801-8. PMID 18005941 DOI: 10.1016/j.biopsych.2007.09.024  0.48
2008 Potvin S, Joyal CC, Pelletier J, Stip E. Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis. Schizophrenia Research. 100: 242-51. PMID 17614260 DOI: 10.1016/j.schres.2007.04.022  0.56
2007 Potvin S, Mancini-Marie A, Fahim C, Mensour B, Stip E. Processing of social emotion in patients with schizophrenia and substance use disorder: an fMRI study. Social Neuroscience. 2: 106-16. PMID 18633810 DOI: 10.1080/17470910701376787  0.56
2007 Potvin S, Sepehry AA, Stip E. Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia. The Australian and New Zealand Journal of Psychiatry. 41: 792-9. PMID 17828652 DOI: 10.1080/00048670701579041  0.56
2007 Fahim C, Stip E, Mancini-Marïe A, Potvin S, Malaspina D. Orbitofrontal dysfunction in a monozygotic twin discordant for postpartum affective psychosis: a functional magnetic resonance imaging study. Bipolar Disorders. 9: 541-5. PMID 17680927 DOI: 10.1111/j.1399-5618.2007.00404.x  0.56
2007 Sepehry AA, Potvin S, Elie R, Stip E. Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a meta-analysis. The Journal of Clinical Psychiatry. 68: 604-10. PMID 17474817  0.56
2007 Potvin S, Mancini-Marïe A, Fahim C, Mensour B, Lévesque J, Karama S, Beauregard M, Rompré PP, Stip E. Increased striatal gray matter densities in patients with schizophrenia and substance use disorder: a voxel-based morphometry study. Psychiatry Research. 154: 275-9. PMID 17341445 DOI: 10.1016/j.pscychresns.2006.11.009  0.48
2007 Levaux MN, Potvin S, Sepehry AA, Sablier J, Mendrek A, Stip E. Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB. European Psychiatry : the Journal of the Association of European Psychiatrists. 22: 104-15. PMID 17227707 DOI: 10.1016/j.eurpsy.2006.11.004  0.48
2007 Potvin S, Sepehry AA, Stip E. Comorbid substance-use in schizophrenia: the file drawer effect, In reply to: Talamo et al., 2006. "Comorbid substance-use in schizophrenia: relation to positive and negative symptoms". Schizophrenia Research. 90: 351-2; author reply . PMID 17055705 DOI: 10.1016/j.schres.2006.09.006  0.56
2006 Potvin S, Stip E, Lipp O, Elie R, Mancini-Marië A, Demers MF, Roy MA, Bouchard RH, Gendron A. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial. Current Medical Research and Opinion. 22: 1277-85. PMID 16834826 DOI: 10.1185/030079906X112561  0.48
2006 Mancini-Marïe A, Potvin S, Fahim C, Beauregard M, Mensour B, Stip E. Neural correlates of the affect regulation model in schizophrenia patients with substance use history: a functional magnetic resonance imaging study. The Journal of Clinical Psychiatry. 67: 342-50. PMID 16649818  0.48
2006 Potvin S, Sepehry AA, Stip E. A meta-analysis of negative symptoms in dual diagnosis schizophrenia. Psychological Medicine. 36: 431-40. PMID 16536885 DOI: 10.1017/S003329170500574X  0.56
2006 Mancini-Marïe A, Fahim C, Potvin S, Beauregard M, Stip E. Quetiapine: focus on emotional numbing in depersonalization disorder: an fMRI case report European Psychiatry. 21: 574-577. PMID 16140509 DOI: 10.1016/j.eurpsy.2005.05.014  0.48
2005 Potvin S, Briand C, Prouteau A, Bouchard RH, Lipp O, Lalonde P, Nicole L, Lesage A, Stip E. CANTAB explicit memory is less impaired in addicted schizophrenia patients. Brain and Cognition. 59: 38-42. PMID 15913868 DOI: 10.1016/j.bandc.2005.04.002  0.56
2005 Tranulis C, Potvin S, Gourgue M, Leblanc G, Mancini-Marie A, Stip E. The paradox of quetiapine in obsessive-compulsive disorder. Cns Spectrums. 10: 356-61. PMID 15858452  0.56
2004 Potvin S, Stip E, Roy JY. The effect of quetiapine on cannabis use in 8 psychosis patients with drug dependency. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 49: 711. PMID 15560324  0.56
2003 Potvin S, Stip E, Roy JY. Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses. International Clinical Psychopharmacology. 18: 121-32. PMID 12702890 DOI: 10.1097/01.yic.0000063501.97247.38  0.56
Show low-probability matches.